Onconova Therapeutics, Inc. Gains 21.63%
Thu, Apr 22, 2021 at 05:30 PM
Onconova Therapeutics, Inc. (ONTX:NASDAQ) soared at $0.8, a gain of 21.6%. On Wed, Apr 21, 2021, ONTX:NASDAQ touched a New 2-Week Intraday Low of $0.59. The stock appeared on our News Catalysts scanner on Thu, Apr 22, 2021 at 08:08 AM in the 'BIOTECH' category. From Wed, Apr 07, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Feb 18, 2021 at $1.93 with a volume of 244M+.
About Onconova Therapeutics, Inc. (ONTX:NASDAQ)
Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 42.92%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 40.22%
- CDAK (CDAK:NASDAQ), 34.64%
- Teradata Corporation (TDC:NYSE), 26.63%
- AENZ (AENZ:NYSE), 25.64%
- UCL (UCL:NASDAQ), 23.07%
- XM (XM:NASDAQ), 22.71%
- CEL-SCI Corporation (CVM:NYSEMKT), 21.7%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 21.63%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 17.86%